Breast Cancer Drug Promising in Phase 3 Trial
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - August 16, 2018 Category: Cancer & Oncology Source Type: news

PARP Inhibitor Talazoparib Benefit in BCRA+ Breast Cancer PARP Inhibitor Talazoparib Benefit in BCRA+ Breast Cancer
The now published results from the EMBRACA study confirm that talazoparib prolongs progression-free survival in advanced BCRA-positive breast cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 15, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Multidisciplinary Approaches to Chest Wall Recurrences of Breast Cancer
A chest wall recurrence of breast cancer following mastectomy is a complex clinical problem that can push centers to the limits of their resources. (Source: CancerNetwork)
Source: CancerNetwork - August 15, 2018 Category: Cancer & Oncology Authors: Cletus Arciero, MD, FACS, Peter Thompson, MD, Jane Lowe Meisel, MD, Caitlin E. Taylor, MD, Mylin A. Torres, MD, William C. Wood, MD Source Type: news

Obese Breast Cancer Patients and Survivors: Management Considerations
This article will present feasible weight loss interventions, and will discuss practical implications of ongoing chemotherapy and endocrine therapy with regard to weight gain, and the impact of obesity on therapy-related conditions during breast cancer survivorship. (Source: CancerNetwork)
Source: CancerNetwork - August 15, 2018 Category: Cancer & Oncology Authors: Jennifer Y. Sheng, MD, Dipali Sharma, MS, PhD, Gerald Jerome, PhD, Cesar Augusto Santa-Maria, MD Source Type: news

Breast Cancer Drug Promising in Phase 3 Trial
WEDNESDAY, Aug. 15, 2018 -- For women with advanced breast cancer who carry the BRCA1 and BRCA2 gene mutations, an experimental drug could improve survival, a new study suggests. The BRCA mutations are linked with a greater risk for aggressive... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 15, 2018 Category: General Medicine Source Type: news

Talazoparib Beneficial in Patients With Advanced Breast Cancer
WEDNESDAY, Aug. 15, 2018 -- Single-agent talazoparib provides significant benefit over standard chemotherapy for patients with advanced breast cancer and germline BRCA1/2 mutation, according to a study published online Aug. 15 in the New England... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 15, 2018 Category: Pharmaceuticals Source Type: news

Medical News Today: What happens at each stage of breast cancer?
There are multiple stages of breast cancer, ranging from 0 –4. Each has it’s own particular set of symptoms and treatment possibilities. There are treatment options for each stage with varying outlooks for success depending on the stage and person. The earlier the stage, the more likely treatment will be successful. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 15, 2018 Category: Consumer Health News Tags: Breast Cancer Source Type: news

PARP inhibitor improves progression-free survival in patients with advanced breast cancers
(University of Texas M. D. Anderson Cancer Center) In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 15, 2018 Category: International Medicine & Public Health Source Type: news

Vaginal Rejuvenation Manufacturers Land in Hot Water with FDA
 Back in February, MD+DI got the low down from an obstetrics and gynecologist specialist in Lubbock, TX on a new vaginal rejuvenation device that her patients have been raving about.  Now it seems the manufacturer of that particular device, along with other companies selling laser- or energy-based devices for vaginal rejuvenation failed to get FDA's blessing. "We've recently become aware of a growing number of manufacturers marketing 'vaginal rejuvenation' devices to women and claiming these procedures will treat conditions and symptoms related to menopause, urinary incontinence, or...
Source: MDDI - August 14, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

Is IBM Really Making Progress with Watson in Healthcare?
Recent media reports have cast doubt on the benefits of IBM's Watson computing system in healthcare, but the company isn't taking the criticism lying down. "I feel it is imperative to set the record straight," John Kelly III, senior vice president of cognitive solutions and IBM research, wrote in a blog post for IBM. IBM has placed a big bet on healthcare, Kelly said.  "We know that AI can make a big difference in solving medical challenges and supporting the work of the healthcare industry," he said, adding that the company also sees an enormous business opportunity in this area as the adop...
Source: MDDI - August 14, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Digital Health Source Type: news

Not all women eligible for breast cancer gene tests are getting them
(Reuters Health) - Tests for BRCA1 and BRCA2 - gene mutations that raise the risk of breast and ovarian cancers - are not always done in U.S. women who are eligible to get them, a new study suggests. (Source: Reuters: Health)
Source: Reuters: Health - August 14, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

IBM pushes back on negative Watson Health stories
IBM Watson Health (NYSE:IBM) is pushing back against reports that its artificial intelligence powered products deliver less than promised, claiming that the reports are unfair and ignore its capabilities. A number of news outlets, including The Wall Street Journal and STAT News, have recently published criticisms of IBM’s Watson Health offerings, claiming that its capabilities fall short of the company’s large promises. “Unfortunately, some media reports, including an August 11th story published in The Wall Street Journal, distort and ignore facts when suggesting IBM has not made ‘enough’...
Source: Mass Device - August 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Software / IT IBM Watson Health Source Type: news

Medically underserved women in the Southeast rarely receive BRCA tests
(Vanderbilt University Medical Center) Medically underserved women in the Southeast diagnosed with breast cancer or ovarian cancer missed out on genetic testing that could have helped them and their relatives make important decisions about their health, according to new research from Vanderbilt-Ingram Cancer Center. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 14, 2018 Category: Cancer & Oncology Source Type: news

Gene Test Predicts Risk of 5 Common Diseases
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - August 14, 2018 Category: Cancer & Oncology Source Type: news

Could HER2 Amplification Aid in the Prognosis of HER2-Positive Breast Cancer?
The presence of HER3 expression and a high HER2/CEP17 ratio distinguish a group of invasive HER2-positive ductal breast cancer patients who have a worse prognosis. (Source: CancerNetwork)
Source: CancerNetwork - August 13, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Clues to Your Health Are Hidden at 6.6 Million Spots in Your DNA
With a sophisticated new algorithm, scientists have found a way to forecast an individual ’ s risks for five deadly diseases. (Source: NYT Health)
Source: NYT Health - August 13, 2018 Category: Consumer Health News Authors: GINA KOLATA Tags: Genetics and Heredity Tests (Medical) Heart Breast Cancer DNA (Deoxyribonucleic Acid) Broad Institute Harvard University Kathiresan, Sekar Source Type: news

Project links state and national patient data registries
Data from the American College of Radiology's National Mammography Database...Read more on AuntMinnie.comRelated Reading: Women dubious about risk-based breast cancer screening Provider factors influence breast cancer screening Shared decision-making for mammography could be clearer Gap narrows in black, white breast cancer death rates Mammography database makes performance tracking easier (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 13, 2018 Category: Radiology Source Type: news

Researchers predict risk for common deadly diseases from millions of genetic variants
(Broad Institute of MIT and Harvard) A research team reports a new kind of genome analysis that could identify large fractions of the population who have a much higher risk of developing serious common diseases, including coronary artery disease, breast cancer, or type 2 diabetes. These tests, which use information from millions of places in the genome to ascertain risk for five diseases, can flag greater likelihood of developing the potentially fatal conditions well before any symptoms appear. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 13, 2018 Category: Biology Source Type: news

Lack of Exercise Can Boost Cancer Risk
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - August 13, 2018 Category: Cancer & Oncology Source Type: news

Is radiation therapy warranted for DCIS postlumpectomy?
Researchers have found that radiation therapy after lumpectomy in women with...Read more on AuntMinnie.comRelated Reading: Microbubbles improve breast cancer radiation therapy ASTRO: Short radiation course safe for breast cancer LED device could predict skin damage from breast RT Robotic IMRT-APBI works well for breast cancer patients SABCS: Study links APBI to higher complication rates (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 10, 2018 Category: Radiology Source Type: news

Lumpectomy Plus RT Tied to Lower Mortality in DCIS Lumpectomy Plus RT Tied to Lower Mortality in DCIS
Lumpectomy plus radiation is associated with a small but statistically significant reduced risk for breast cancer-related death compared to the other major options for ductal carcinoma in situ (DCIS).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Nanostring: BC360 Breast Cancer Classification
Classifying tumors for optimal therapeutic accuracy (Source: The Scientist)
Source: The Scientist - August 10, 2018 Category: Science Tags: Sponsored Videos Source Type: news

Pfizer advanced breast cancer drug gets China ok
The China National Drug Administration has granted approval of Pfizer ’s Ibrance, the world's first CDK 4/6 selective inhibitor. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 10, 2018 Category: Pharmaceuticals Source Type: news

Corner Office: Paula Schneider on Running American Apparel and Fighting Cancer
A breast cancer survivor who ran one of the most notorious brands in fashion is now C.E.O. of Susan G. Komen, working to raise money for a cure. (Source: NYT Health)
Source: NYT Health - August 10, 2018 Category: Consumer Health News Authors: DAVID GELLES Tags: Breast Cancer Fashion and Apparel American Apparel Inc Komen, Susan G, for the Cure Schneider, Paula Charney, Dov Source Type: news

Association of radiation therapy plus lumpectomy in reduced risk of dying in women with DCIS
(JAMA Network) Lumpectomy plus radiation was associated with a small clinical benefit in reduced risk of breast cancer death compared with lumpectomy or mastectomy alone   in women   with ductal carcinoma in situ (DCIS), a noninvasive early form of breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 10, 2018 Category: Cancer & Oncology Source Type: news

The Recommended Dose podcast: Alexandra Barratt on using both medicine and the media to explore and promote the critical role of evidence in healthcare
Episode 12 -Alexandra Barratt' It's not science or instinct...it's evidence and personal preferences. That's really, to me, the heart of shared decision making. ’This week ’s guest has led something of a double life, using both medicine and the media to explore and promote the critical role of evidence in healthcare. Now based at the University of Sydney, Alexandra Barratt's journey from clinician to journalist to global advocate for evidence based medicine and shared decision-making is a fascinating one.Here she talks with acclaimed journalist and health researcher ,Dr Ray Moynihan, about her varied career and...
Source: Cochrane News and Events - August 9, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Triple-Negative Breast Cancer Genes ID'd
Title: Triple-Negative Breast Cancer Genes ID'dCategory: Health NewsCreated: 8/8/2018 12:00:00 AMLast Editorial Review: 8/9/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - August 9, 2018 Category: Cancer & Oncology Source Type: news

Nanoparticle therapy could deliver double blow to cancer
(University of East Anglia) A new cancer therapy using nanoparticles to deliver a combination therapy direct to cancer cells could be on the horizon.Using nanoparticles to get drugs directly into a tumor is a growing area of cancer research. The technology developed at UEA is the first of its kind to use nanoparticles to deliver two drugs in combination to target cancer cells. The therapy has been shown to make breast cancer and prostate cancer tumors more sensitive to chemotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 9, 2018 Category: International Medicine & Public Health Source Type: news

Cardiac Monitoring Lacking in Patients With Breast Cancer Cardiac Monitoring Lacking in Patients With Breast Cancer
Less than half of women receiving trastuzumab underwent guideline-recommended cardiac monitoring, but observers suggest that more tailored monitoring may be the way forward.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 8, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Triple-Negative Breast Cancer Genes ID'd
The team also found that mutations in the BRIP1 and RAD51C genes were associated with a more moderate risk of triple-negative breast cancer. (Source: WebMD Health)
Source: WebMD Health - August 8, 2018 Category: Consumer Health News Source Type: news

Triple - Negative Breast Cancer Genes ID ’ d
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 8, 2018 Category: Cancer & Oncology Tags: Oncology, Research, News, Source Type: news

Damascus: Syria's first lady starts breast cancer treatment
Syria's presidency says first lady Asma Assad has begun treatment for breast cancer (Source: ABC News: Health)
Source: ABC News: Health - August 8, 2018 Category: Consumer Health News Tags: Health Source Type: news

Triple-Negative Breast Cancer Genes ID'd
WEDNESDAY, Aug. 8, 2018 -- More genes associated with an increased risk of triple-negative breast cancer have been identified by researchers. Until now, only mutations in the BRCA1 gene have been linked with this type of breast... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 8, 2018 Category: General Medicine Source Type: news

Gambia:First Lady - Gambia Making Progress Against Breast Cancer
[Govt of the Gambia] State House, Banjul, 7th August 2018 - The First Lady of the Republic, Her Excellency Fatoumatta Bah-Barrow has said the Gambia is making a steady progress in the fight against breast and cervical cancers, despite the high infection rates being registered across the sub region. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 8, 2018 Category: African Health Source Type: news

High-risk breast cancer patients need cardiac monitoring
Some chemotherapy treatments for breast cancer increase a woman's risk of heart...Read more on AuntMinnie.comRelated Reading: ASTRO: Imaging, radiation oncology increasingly work as one Breast cancer patients aren't getting heart disease treatment CE-MRI predicts survival in breast cancer patients after chemo JNM: Cancer patients need cardiac review Trastuzumab + RT = no cardiac risk in breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 8, 2018 Category: Radiology Source Type: news

Ultrasound elastography helps identify invasive breast cancer
Ultrasound using a shear-wave elastography technique can help clinicians determine...Read more on AuntMinnie.comRelated Reading: How serious is the risk of breast cancer overdiagnosis? Does double reading improve breast cancer screening? Surveillance OK for certain type of breast lesion Breast AI algorithm could reduce unnecessary surgery by 30% ARRS: Don't underestimate breast US in cancer arsenal (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 8, 2018 Category: Radiology Source Type: news

Triple-Negative Breast Cancer Genes ID'd
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - August 8, 2018 Category: Cancer & Oncology Source Type: news

Triple-Negative Breast Cancer Genes ID'd
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - August 8, 2018 Category: Cancer & Oncology Source Type: news

Heart Monitoring a Must for Breast Cancer Patients on Herceptin
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - August 8, 2018 Category: Cancer & Oncology Source Type: news

Adding TKIs Could Increase Responses in Metastatic HER2+ Breast Cancer
A laboratory study found that combining anti-HER2 TKIs with trastuzumab and pertuzumab can result in enhanced anticancer activity in HER2+ breast cancer cell lines. (Source: CancerNetwork)
Source: CancerNetwork - August 7, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Jade Goffin, woman dying from brain cancer makes £250k therapy plea
Jade Goffin, 30, from London, thought she'd beaten a rare form of breast cancer after undergoing treatment. But she was heartbroken to find it then spread into her brain... (Source: the Mail online | Health)
Source: the Mail online | Health - August 7, 2018 Category: Consumer Health News Source Type: news

Women On Herceptin Need Regular Heart Checks
Women who take the chemotherapy drug trastuzumab (Herceptin) for HER2-positive breast cancer can be at higher risk for heart failure and should have their hearts monitored during treatment, new research finds. The complication is not common, and in many cases, the benefits of the chemotherapy still outweigh the risks. But regular checks should be a priority. (Source: WebMD Health)
Source: WebMD Health - August 7, 2018 Category: Consumer Health News Source Type: news

Heart Monitoring a Must for Breast Cancer Patients on Herceptin
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 7, 2018 Category: Cancer & Oncology Tags: Cardiology, Gynecology, Oncology, Pharmacy, Preventive Medicine, News, Source Type: news

Heart Monitoring a Must for Breast Cancer Patients on Herceptin
TUESDAY, Aug. 7, 2018 -- The widely used chemotherapy drug trastuzumab (Herceptin) can be life-saving for women with HER2-positive breast cancer, a particularly aggressive form of the disease. But new research now adds to mounting evidence that the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 7, 2018 Category: General Medicine Source Type: news

Heart Monitoring a Must for Breast Cancer Patients on Herceptin
Title: Heart Monitoring a Must for Breast Cancer Patients on HerceptinCategory: Health NewsCreated: 8/7/2018 12:00:00 AMLast Editorial Review: 8/7/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - August 7, 2018 Category: Cancer & Oncology Source Type: news

FES-PET enhances treatment for metastatic breast cancer
By identifying differences in estrogen receptor expression through PET imaging...Read more on AuntMinnie.comRelated Reading: FES-PET detects estrogen-receptor-positive breast cancer PET aids tough breast cancer cases (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 7, 2018 Category: Radiology Source Type: news

Women dubious about risk-based breast cancer screening
Women are skeptical about risk-based breast cancer screening protocols, according...Read more on AuntMinnie.comRelated Reading: Would risk-based breast screening be more cost-effective? Breast MRI underutilized in high-risk women Twitter hashtag war erupts over breast screening Is screening breast MRI being used in the wrong women? What are the risks of risk-based breast cancer screening? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 7, 2018 Category: Radiology Source Type: news

Problems persist for breast cancer detection in Morocco
In advance of ECR 2019's focus on Africa, we have a special report about Morocco....Read more on AuntMinnie.comRelated Reading: Research spotlights breast screening shortfall in Iran Breast cancer care in Afghanistan presents challenges Large Egyptian study shows breast cancer, density link Mobile ultrasound brings care to rural areas in Morocco Breast cancer risk profiles differ in developing nations (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 7, 2018 Category: Radiology Source Type: news

Back to the future: breast cancer reprises pathways found in fetal cells
(Salk Institute) Salk Institute scientists have uncovered a reason for the uncanny likeness between cells in the most malignant cancers and the embryonic cells of the organ in which the cancer originated: cells in human basal-like breast cancers share features with the embryonic mammary (breast) stem cells that are the progenitors of all cell types in the mammary gland (of a mouse). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 7, 2018 Category: Cancer & Oncology Source Type: news

Paper identifies genes associated with risk for aggressive breast cancer
(Oxford University Press USA) A new study published in the Journal of the National Cancer Institute has identified specific genes associated with increased risk for triple-negative breast cancer, providing the basis for better risk management. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 7, 2018 Category: International Medicine & Public Health Source Type: news